After 10 years of eCTD the standard is fit for rejuvenation. Although eCTD has brought many benefits there is still significant room for improvement. This presentation covers different areas: continuous challenges associated with eCTD, Regulatory guidelines and eCTD viewing
5. The Aging process
First European eCTD: 24th
January 2003
eCTD v3.0
EU v0.9
Mandated by EMA (1st January
2010)
Ability to accept e-only (January
2010)
EMA Gateway (2012)
(mandatory 1st March 2014
12/5/2013
Copyright Qdossier B.V.
10. eCTD viewer vs. Tracking approval
Baseline of the
current EU dossier
please!
12/5/2013
Latest submitted or
current approved?
Copyright Qdossier B.V.
11. Current in eCTD vs. Current Approved
Source: IRISS Life Cycle Group 2009
12/5/2013
Copyright Qdossier B.V.
12. Document Lifecycle status
Life cycle operation: “New”
Life cycle status: “Current”
Approval status: “Under review”
12/5/2013
Copyright Qdossier B.V.
14. FDA –Providing Regulatory Submissions in
Electronic Format (draft)
“Although some eCTD tools generate leaf titles
that are similar to file names, the two are not
related.”
All modules of the eCTD should contain
descriptive eCTD leaf titles that are:
Short
Meaningful
Indicative of each document's content
Not including the eCTD section number
12/5/2013
Copyright Qdossier B.V.
15. Leaf titles vs. File names
12/5/2013
Copyright Qdossier B.V.
16. Swiss Medic - Providing Regulatory
Information in eCTD Format version
Hyperlinks are encouraged to facilitate
navigation > should not be overused
Only if necessary and of real added value.
Important eCTD titles are consistent with cross
references within other documents (e.g. summary
document)
Hyperlinks needed if title in eCTD ToC and
reference in a summary document do not match
12/5/2013
Copyright Qdossier B.V.
17. Validation
To assure that what has been submitted is fit for
review by the validating agency
Technical: Can technically be processed by agencies?
Business: All data is available to examine the quality,
safety and efficacy of the drug
12/5/2013
Copyright Qdossier B.V.
18. Technical validation > …. < Business
validation
Consistency in attribute values
across sequences
attributes, file names and folder names within a
sequence
Country codes
Language codes
PI Doc types
Proper reference to “Related Sequence”
12/5/2013
Copyright Qdossier B.V.
19. Additional “common sense” checks
Cover letter and Application form data is reflected
correctly in the envelope
Use of meaningful titles; e.g.
Proof of Payment vs. Annex 5.2
Note to Reviewer vs. Annex 3
Stability Data Long Term Stability 24 M vs. Stability Data 1
Use of meaningful file names; e.g.
de-form-proofpayment.pdf
vs.
de-form-5.pdf
es-cover-notereviewer.pdf
vs.
es-cover-3.pdf
stability-data-longterm24m.pdf
vs.
stability-data-1.pdf
analytical-procedure-identityelisa.pdf
validation-analytical-procedure-identityhplc.pdf
12/5/2013
Copyright Qdossier B.V.
20. Conflicting guidelines
eCTD: “do not resubmit the same
document”
CTD (Renewals): “include a copy of the
latest specifications”
eCTD: leave empty
CTD: placeholders “N/A”
12/5/2013
Copyright Qdossier B.V.
21. Controlled vocabulary
“Regulatory activity”
HL7: “the provision of information about a regulated
product(s) requiring a scientific or regulatory outcome. An
activity may include one or many exchanges (examples of
exchanges may be eCTD sequences, RPS submission
units, etc.)”.
CESP:
12/5/2013
Copyright Qdossier B.V.
23. Controlled vocabulary (Cont’d)
“Working documents means draft versions of
summary of product characteristics, package
leaflet, and labeling editable by the Danish Health
and Medicines Authority”
QOS and (non-)Clinical overview?
12/5/2013
Copyright Qdossier B.V.
24. Errors in guidance
<sequence number>-working documents
„sequence number - workingdocuments’ (no
hyphen)
12/5/2013
Copyright Qdossier B.V.
34. eCTD yesterday
Envelope information + other metadata
<cc> SmPC
Agency codes
EMEA = EMA
DKMA = DHMA
USKVBL
AEMPS = ES-AEMPS
Country codes
AT - Austria
BE - Belgium
CZ - Czech Rep.
DE - Germany
DK - Denmark
SmPC ES - Spain
FI - Finland
HR - Croatia
12/5/2013
Copyright Qdossier B.V.
35. eCTD day before yesterday
Envelope information + other metadata
GMO
Non-GMO
Orphan
DSUR
PSMF
RMP
GMO
12/5/2013
RMP
Copyright Qdossier B.V.
RtQ
36. XEVMPD/IDMP principles
XSD schema defining structure
CV
Substance
List of
allowed
substance
names
12/5/2013
CV
Substance
Metadata
List of
allowed ATC
codes
ISO 3166-1
List of
country
codes
Regional
Implementation
guideline
Validation
Copyright Qdossier B.V.
37. eCTD tomorrow?
RMP
Controlled
CV List of
Vocabulary
allowed
labels:
List of
allowed
GMO
Non-GMO
labels
(Agency
DSUR
controlled)
RMP
DSUR
v1.0
12/5/2013
Copyright Qdossier B.V.
38. Allows easy updating of…
Use of the European Agency Acronym
Addition of Other PDF Versions
Addition of Risk Management Plan as a
New Submission Type
Revisions Regarding Agency Names and
Agency Codes
Source: Release notes EU module 1 specification v2.0
12/5/2013
Copyright Qdossier B.V.
39. Concluding remarks
Continuous education needed
Agency focus moves from technical to non-technical
aspects
(Much) broader/ leaner technical specifications needed
for structure
Well specified implementation guidelines and controlled
vocabulary to assure correct use
Correct application assured by validation tools
(Hopefully with some build in consistency checks)
12/5/2013
Copyright Qdossier B.V.